Nicotine Replacement Therapy

The use of e-cigarettes as a smoking cessation method did not significantly prevent relapse or successful termination, according to survey findings published in Tobacco Control.

Using a combination of nicotine replacement therapy and varenicline may be more effective as first-line therapy for smoking cessation than varenicline alone, according to data presented at the CHEST Annual Meeting.

In the randomized E3 trial, nicotine e-cigarettes combined with individual counseling was more effective for smoking cessation at 12 weeks than non-nicotine e-cigarettes with counseling or counseling alone.

Combining reduced-harm nicotine products can lead to improvement in smoking cessation without short-term harm, according to a study published in The Lancet Respiratory Medicine.

Varenicline did not appear associated with increased risk for cardiovascular or neuropsychiatric hospitalization compared with nicotine replacement therapies, according to a retrospective new-user cohort study published in Addiction.

Nearly all Medicaid-insured adolescents and young adults with diagnosed nicotine use disorder, or NUD, do not receive counseling or pharmacologic treatment for their condition, according to research published in JAMA Pediatrics.